# Carnitine for the Treatment of Atherosclerosis.

> **NCT02117661** · PHASE2 · COMPLETED · sponsor: **Dr. Amer Johri** · enrollment: 177 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** L-carnitine capsules
- **DIETARY_SUPPLEMENT:** Cellulose capsules

## Key facts

- **NCT ID:** NCT02117661
- **Lead sponsor:** Dr. Amer Johri
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-07
- **Final completion:** 2019-05
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2020-06-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117661, "Carnitine for the Treatment of Atherosclerosis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02117661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*